Two (2) Clinical Chemistry/Immunoassay Analyzers, Reagents, Consumables, QC, Maintenance at Branch Health Clinics Makalapa & Kaneohe Bay, Hawaii
Closed Pre-Solicitation Posted
Not the latest version. See the latest solicitation from .
- Solicitation number
- HT941024N0017
- Agency
-
Defense Health Agency
Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6630 Chemical Analysis Instruments
- Place of performance
- Jbphh, Hawaii 96860, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Health Agency intends to award a sole source contract to Roche Diagnostics Corporation to provide two clinical chemistry/immunoassay analyzers, related consumables, reagents, quality control, and maintenance for Branch Health Clinic Makalapa and Branch Health Clinic Kaneohe Bay in Hawaii. The analyzers must be capable of performing general chemistry, specialty chemistry, immunoassay, electrolyte, therapeutic drug, drugs of abuse, toxicology, diabetes, hepatic, thyroid, cardiac, anemia, and autoimmune testing. Interested parties have until December 18, 2023 to submit capability statements challenging the sole source basis for evaluation.
There are no set-aside designations for this requirement. The intended procurement will be classified under NAICS code 334516 for automatic environmental control manufacturing. Roche Diagnostics Corporation is identified as the potential incumbent. The base period of performance is January 2024 to June 2024 with an option to extend to December 2024. One analyzer must be capable of 1,000 tests per hour and the other 375 tests per hour.
Notice text
THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE SUPPLY CONTRACT AND IS NOT A REQUEST FOR COMPETITIVE QUOTES. The Defense Health Agency intends to negotiate on a sole source basis IAW FAR 13.501(a), Only One Responsible Source. The proposed source is Roche Diagnostics Corporation, 9915 Hague Rd, Indianapolis, Indiana, 46256-1025.
The requirement is for a contract for two (2) analyzers, laboratory, clinical chemistry/immunoassay [20- 821], reagents, quality control, maintenance, and consumables for Naval Health Clinic (NHC) Hawaii. One (1) clinical chemistry/immunoassay analyzer shall be for Branch Health Clinic (BHC) Makalapa, and one (1) clinical chemistry/immunoassay analyzer shall be for BHC Kaneohe Bay. The contracted analyzers shall be capable of performing general chemistry, special chemistry, immunoassay, and screening for electrolytes, therapeutic drugs, drugs of abuse, toxicology, diabetes, hepatic diseases, thyroid diseases, cardiac diseases, anemia panels, and autoimmune diseases, as defined below. The contracted analyzers for each clinic shall be capable of performing the tests listed below at the yearly indicated test volume. The contracted analyzers for BHC Makalapa and BHC Kaneohe Bay shall have the same test platform to ensure accuracy of results between clinics. The contractor shall be capable of 24 hour response time. The contractor shall be available for telephone troubleshooting consultation 24 hours a day, 7 days a week, 365 days per year, except on Federal holidays. The contract shall include operator training.
BHC Makalapa Requirements:
The contracted analyzer shall be capable of completing a minimum of 1,000 tests per hour. The contracted analyzer shall fit within the following dimensions: 52 inches (H) x 122 inches (W) x 52 inches (D). The contracted analyzer shall perform the annual estimated test volume as indicated in the attached Notice. The contracted analyzer shall also include FT3, FT4, and HCG, B at no cost, as needed.
BHC Kaneohe Bay Requirements:
The contracted analyzer shall be capable of completing a minimum of 375 tests per hour. The contracted analyzer shall fit within the following dimensions: 50 inches (H) x 100 inches (W) x 34 inches (D). The contracted analyzer shall perform the annual estimated test volume as indicated in the attached Notice. The contracted analyzer shall also include FT3, FT4, and HCG, B at no cost, as needed.
1. Equipment
a. The analyzers shall utilize liquid, ready-to-use reagents and shall not require the manipulation/reconstitution of reagents for testing
b. The analyzers shall not require major facility changes beyond electrical.
c. The analyzers shall be capable of adding new third party tests.
d. The analyzers shall be capable of utilizing the following sample types without the need for the following pre-treatments: serum, plasma, urine, and cerebrospinal fluid (CSF).
e. The analyzers shall be capable of automatic quality control (QC) and automatic calibration
f.The analyzers shall be capable of pre-calibrating and storing at least two (2) lots onboardthe unit.
g.The analyzers shall have sufficient onboard storage to accommodate daily workload asoutlined above.
h.The analyzers shall complete STAT (urgent) requests in, at most, 60 minutes.
i.The analyzers shall be capable of auto-dilution.
j.The analyzers shall be capable of utilizing sample tube bar codes for accurate sampleidentification.
k.The analyzers shall be capable of interfacing with the Composite Health Care System(CHCS) laboratory information management system.
l.The analyzers shall include programmable panels to accommodate in-house needs.
m.The analyzers shall be capable of starting up without priming or washes.
n.The analyzers shall be capable of external data storage in compliance withNavy/Department of Defense (DoD) Information Assurance (IA) regulations.
o.The analyzers shall include an uninterruptible power supply (UPS) that is compatiblewith all system components, is capable of conditioning the power to the system, andallows the system a minimum of 30 minutes run time in case of a power outage.
p.The power requirement is 250 VAC, 60 Hz, 30 Amps, single phase.Periods of Performance Base: 01 January 2024 - 30 June 2024 OPT1: 01 July 2024 - 31 December 2024 There are not set-aside restrictions for this requirement. The intended procurement will be classified under North America Industry Classification System (NAICS) 334516. This notice of intent is not a request for competitive proposals and no solicitation document exists for this requirement. However, parties interested in responding to this notice will need to submit technical data sufficient to determine capability in providing the same product. All capability statements received by the closing date of this synopsis will be considered by the Government. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. If a vendor challenges the basis of this requirement, please email product capability statements (formats for submission: PDF, MS Word, or MS Excel) to Nicole Ventinilla at nicole.e.ventinilla.civ@health.mil. Closing date for challenges is no later than 0800 PST on 18 December 2023. No phone calls will be accepted.
Files
| File | Type | Posted |
|---|---|---|
| HT941024N0017 NOI to Sole Source.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Notice of Intent to Sole Source Platelet-Rich-Plasma Kits for Naval Hospital Camp Pendleton from BioRich Medical, Inc. | Solicitation | |
| This notice | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Analyzer, blood choles | Medical Supply Chain | No set-aside | |
| 6550-- Roche Ventana Reagents IDIQ 5 Successive 1 Year Delivery Orders | Veterans Integrated Service Network 16 | No set-aside | |
| Reagents and consumables for Roche immunostainers | Office of Logisitics and Acquisition Operations | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity